Literature DB >> 32591411

Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma.

Fa Yang1, Yan Wei2, Donghui Han1, Yu Li1, Shengjia Shi1, Dian Jiao3, Jieheng Wu4, Qiang Zhang5, Changhong Shi6, Lijun Yang1, Wei Song1, Jingliang Zhang1, Yueheng Han7, Rui Zhang4, An-Gang Yang4, Dimiter S Dimitrov8, Aizhi Zhao7, Weijun Qin9, Weihong Wen10.   

Abstract

Fibroblasts and macrophages play key roles in the development of hepatocellular carcinoma (HCC). However, cross-talk between these two kinds of cells has not been well studied. Endosialin (CD248/TEM1) is a transmembrane glycoprotein that is expressed in certain cancer cells, tumor stromal cells, and pericytes. In this study, we found that endosialin is mainly expressed in cancer-associated fibroblasts (CAF) in HCC and its expression inversely correlates with patient prognosis. Endosialin interacted with CD68 to recruit macrophages and regulated expression of GAS6 in CAFs to mediate M2 polarization of macrophages. The fully human antibody IgG78 bound glycosylated endosialin and induced its internalization in CAFs, thus weakening the cross-talk between CAFs and macrophages. In subcutaneous and orthotopic xenograft models of HCC in nude mice, treatment with IgG78 significantly inhibited tumor growth. These results indicate that endosialin-positive CAFs promote HCC progression and highlight IgG78 as a promising therapeutic candidate for HCC treatment. SIGNIFICANCE: These findings highlight CAF-expressed endosialin as a primary regulator of macrophage recruitment and polarization and demonstrate endosialin inhibition as a potential treatment strategy for HCC. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/18/3892/F1.large.jpg. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32591411     DOI: 10.1158/0008-5472.CAN-19-2691

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  CD248+CD8+ T lymphocytes suppress pathological vascular remodeling in human thoracic aortic aneurysms.

Authors:  Xiaojuan Hu; Ting Wu; Chenxi Wang; Jun Li; Chunmei Ying
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-31

Review 2.  Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages.

Authors:  Jingyi Zhou; Weiyu Wang; Qi Li
Journal:  J Exp Clin Cancer Res       Date:  2021-02-17

Review 3.  MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Authors:  Chao-Ju Chen; Yu-Peng Liu
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-06

4.  Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.

Authors:  Cong Wang; Chuzhi Shang; Xiaohong Gai; Tao Song; Shaoshan Han; Qingguang Liu; Xin Zheng
Journal:  Front Cell Dev Biol       Date:  2021-04-06

Review 5.  Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities.

Authors:  Ester García-Pras; Anabel Fernández-Iglesias; Jordi Gracia-Sancho; Sofía Pérez-Del-Pulgar
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

6.  CD248+ Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma.

Authors:  Chao Xu; Keying Zhang; Fa Yang; Xiang Zhou; Shaojie Liu; Yu Li; Shanjin Ma; Xiaolong Zhao; Tong Lu; Shiqi Lu; JiaYu Zhang; Hongji Li; Donghui Han; Weihong Wen; Weijun Qin
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

7.  CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma.

Authors:  Shaojie Liu; Chao Xu; Keying Zhang; Donghui Han; Fa Yang; Yu Li; Xiaolong Zhao; Shanjin Ma; Hongji Li; Shiqi Lu; Tong Lu; Jiayu Zhang; Weijun Qin; Weihong Wen; Bo Yang
Journal:  Ann Transl Med       Date:  2021-12

8.  Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder.

Authors:  Yu Li; Keying Zhang; Fa Yang; Dian Jiao; Mingyang Li; Xiaolong Zhao; Chao Xu; Shaojie Liu; Hongji Li; Shengjia Shi; Bo Yang; Lijun Yang; Donghui Han; Weihong Wen; Weijun Qin
Journal:  Front Oncol       Date:  2021-11-17       Impact factor: 6.244

Review 9.  CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.

Authors:  Gurcan Gunaydin
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

Review 10.  Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.

Authors:  Deyang Wu; Xiaowei Liu; Jingtian Mu; Jin Yang; Fanglong Wu; Hongmei Zhou
Journal:  Biomolecules       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.